ghk cu human studies GHK-Cu Peptide ghk-cu hair growth human studies
Description
The new approval for Retevmo, which was previously authorized to treat patients 12 and older with RET-positive thyroid cancers, is based on a single-arm study that showed an overall response rate of 48%, with a median duration of response not reached after 12 months of follow-up
Mood and Motivation: Some individuals find that boosting neurotrophic factors correlates with better mood regulation and a heightened sense of motivation or mental clarity
Limitations: No human trials exist for Alzheimer's, Parkinson's, or general cognitive decline
The website has articles on B12 deficiency in children
